Sinus Node: Normal and Abnormal Rhythms

Normal sinus node


Normal sinus rhythm (NSR) is an atrial rhythm caused by electrical activation that originates from the sinus node, a structure located in the area of the junction of the right atrium and superior vena cava. NSR P waves, representing atrial depolarization (but not sinus node activity itself), are upright in leads I and aVL and the inferior leads (II, III, aVF), indicating the high to low atrial activation pattern ( Fig. 1.1 ). The P wave in leads V 1 -V 2 may be upright, biphasic, or slightly inverted, whereas the P waves in leads V 3 -V 6 tend to be upright, indicating right to left atrial activation. The P-wave morphology may change with alterations in autonomic tone, heart rate, and atrial abnormalities such as hypertrophy. High vagal tone can be associated with a more inferior exit of the impulse from the sinus node, whereas high sympathetic tone can be associated with a more superior exit from the node.

Figure 1.1

Normal sinus rhythm.

Normal sinus rhythm is characterized by P waves that are usually upright in leads I, aVL, II, III, aVF, and V 3 -V 6 at a rate between 60 and 100 bpm.

Clinical Symptoms and Presentations

NSR is generally considered to have a rate of 60 to 100 beats per minute (bpm), although 50 bpm is still normal. Rate changes with alterations in autonomic tone; at rest, most individuals have their heart rate regulated by the vagus nerve.

Individuals with high vagal tone (such as those who are in excellent physical condition) may exhibit sinus arrhythmia, a normal rhythm in which the rate varies with respiration ( Fig. 1.2 ). In sinus arrhythmia, inspiration increases the rate and expiration decreases the rate. Sinus arrhythmia is common during sleep and in patients with obstructive sleep apnea, in which the decrease in rate can be substantial.

Figure 1.2

Normal sinus rhythm with sinus arrhythmia.

This lead V 1 and II rhythm strip shows normal sinus rhythm with sinus arrhythmia, in which the P-P intervals vary by greater than 0.16 seconds. Sinus arrhythmia is often related to respiratory cycles.

Various forms of sinus arrhythmia exist, including a non–respiration-dependent form that may indicate sinus node dysfunction (SND).

Ventriculophasic sinus arrhythmia is present when alterations in the sinus rate are due to atrioventricular (AV) block: The P-P intervals enclosing a QRS complex are shorter than P-P intervals not enclosing a QRS complex.

A change in sinus rate can be gradual or abrupt and can occur with change in body position and exercise. Patients who are in good physical condition generally have more gradual acceleration in sinus rate with exercise and a rapid slowing of the sinus rate at the end of exercise, compared with less physically fit individuals or individuals with heart disease. Higher resting sinus rates have been associated with increased risk for overall mortality.

Wandering atrial pacemaker (WAP) ( Fig. 1.3 ) occurs in association with high vagal tone and is a benign rhythm. In WAP, there are varying exit points of the sinus impulse from the sinus node or impulses that originate from the sinus node and wander from the node to the low atrium and back. WAP is often seen in patients with sinus arrhythmia. WAP should not be confused with “multifocal atrial rhythm” (see Fig. 3.13 ).

Figure 1.3

Wandering atrial pacemaker.

This lead V 1 II, and V 5 rhythm strip shows wandering atrial pacemaker. There are at least three P wave morphologies.

Approach to Management

Although sinus rhythm generally does not require any treatment, an inability to increase the sinus rate appropriately in response to increases in metabolic needs (“chronotropic incompetence”) may require permanent rate responsive cardiac pacing when it is documented to cause symptoms. Definitions of chronotropic incompetence are many and varied, and there is no general agreement as to its parameters.

Sinus node dysfunction, including sinus bradycardia and tachycardia-bradycardia syndrome


Sinus bradycardia (SB) ( Fig. 1.4 ) is generally defined as sinus rates of less than 60 bpm, although 50 bpm is likely within the normal range of rate. SB is often a normal finding in young, healthy adults, especially in athletes with high vagal tone. SB frequently occurs at rest and during sleep. In trained athletes or individuals with high vagal tone, sinus rates in the 40s and even at times in the 30s, especially during sleep, are not uncommon. SB may be associated with a narrow QRS complex or, in the presence of bundle branch block (BBB) or intraventricular conduction delay, with a wide QRS complex ( Fig. 1.5 ).

Figure 1.4

Sinus bradycardia.

This lead II rhythm strip shows SB, which is characterized by sinus P waves (usually upright in leads II, III, aVF) with rate less than 60 bpm.

Figure 1.5

Sinus bradycardia with a wide QRS complex.

Although the QRS complex is normally narrow (< 0.12 seconds), the QRS can be wide in the setting of bundle branch block or intraventricular conduction delay. This 12-lead ECG with rhythm strips of leads V 1 , II, and V 5 shows sinus bradycardia with sinus arrhythmia (rates 53-56 bpm) and left bundle branch.

The sinus rate normally slows with age. SND from sinus node degeneration is more frequent in older persons. SND, sometimes termed “sick sinus syndrome,” is a very common arrhythmia and includes sinus pauses, sinus arrest, inappropriate SB, chronotropic incompetence, sinoatrial (SA) exit block, combinations of SA and AV conduction abnormalities, and tachycardia-bradycardia (tachy-brady) syndrome (e.g., paroxysmal or persistent atrial tachyarrhythmias with periods of bradycardia or postconversion sinus pauses) ( Fig. 1.6 ).

Figure 1.6

Tachycardia-bradycardia syndrome.

This rhythm strip tracing shows an atrial tachyarrhythmia (atrial flutter/tachycardia) that suddenly terminates. The tachycardia is followed by a 3.4-second pause and then sinus bradycardia. The combination of a tachycardia that is suddenly followed by a bradycardia is characteristic of tachy-brady syndrome.

Associated Conditions

SB is often associated with sinus arrhythmia, escape rhythms (junctional and ventricular), accelerated rhythms (junctional and ventricular), atrial arrhythmias, WAP, or SA or AV Wenckebach-like periods. SB is usually benign but can be associated with certain conditions and diseases, including hypothyroidism, vagal stimulation, carotid sinus hypersensitivity, increased intracranial pressure, myocardial infarction (MI), and drugs such as β-adrenergic blockers (including those used for glaucoma), calcium channel blockers, amiodarone, sotalol, clonidine, lithium, and parasympathomimetic drugs. SB occurs in 14% to 36% of MIs and can be associated with AV block. The bradycardia usually resolves without the need for chronic therapy. SB is usually associated with inferior-posterior infarction (caused by increased vagal tone from stimulation of vagal afferents, the Bezold-Jarisch reflex). Clinical syndromes, such as neurocardiogenic syncope and some specific rhythm disorders such as tachy-brady syndrome, can be associated with symptomatic bradycardia as well as symptoms caused by rapid ventricular rates during atrial fibrillation or flutter; severe SB or sinus arrest can occur after spontaneous conversion prior to recovery of the sinus node. SB can be exacerbated by drugs that are used to slow AV node conduction during atrial arrhythmias.

Clinical Symptoms and Presentation

SB is asymptomatic in the vast majority of patients. When present, symptoms may include fatigue, effort intolerance, palpitations, dizziness, lightheadedness, near syncope, syncope, dyspnea, and angina. SND, including chronotropic incompetence, can impair cardiac output or exacerbate heart failure and can be associated with or trigger atrial arrhythmias (e.g., atrial fibrillation) and ventricular arrhythmias (e.g., torsades de pointes). Hemodynamic tolerance of SB is a function of heart rate (a rate of < 30 bpm is usually not well tolerated), underlying disease (less tolerated with poor ventricular function), and age (better tolerated in those < 50 years old). Tachy-brady syndrome may present with rapid palpitations during atrial arrhythmias and lightheadedness, dizziness, near syncope, and/or syncope during postconversion pauses. SND and/or tachy-brady syndrome can result from cardiac surgery, particularly associated with right atriotomy. SND is relatively common after heart transplantation, as the donor atria can be damaged by ischemia and by atrial anastomoses. The sinus node of the native heart rarely interacts with or affects the transplanted sinus rate. Other causes of SB and/or pauses in heart transplant patients include drugs (rare), trauma, and rejection.

Approach to Management

Evaluation or treatment often is unnecessary if the patient is asymptomatic. Treatment depends on the nature of the rhythm disturbance and is usually directed toward prevention of symptoms. Asystole can be life-threatening, but more often it causes symptoms and is due to vagal surges or SND. Asystolic pauses in a young, otherwise healthy person are generally due to vagal surges related to a neurocardiogenic response. An asystolic response after cardioversion, after a tachycardia, and in a patient who is older or has heart disease is often due to SND. Because SND can be subclinical but exacerbated by medical therapy, rate-slowing drugs should be avoided if possible.

A heart rate less than 30 bpm is an indication to evaluate further for treatment. Symptoms caused by SND can be difficult to assess. Exercise testing (if feasible with a temporary pacemaker if a previous exercise test showed inappropriate heart rate response) can help distinguish the cause of symptoms. If severe SND (i.e., SB associated with sinus exit block, sinus pauses, and sinus arrest) is suspected but cannot be documented by physical examination, telemetry monitor strip, or electrocardiogram (ECG), it can be evaluated further with a Holter monitor (low sensitivity), event monitor, implantable loop recorder, or electrophysiology test (low sensitivity and specificity).

The timing of the pauses or the bradycardia is important. It is not uncommon for a patient to develop SB or asystolic episodes during sleep. Although often caused by enhanced vagal tone, this may in some patients be related to sleep apnea. If pauses are seen during sleep on telemetry or Holter monitoring, sleep apnea should be considered and ruled out.

Short-term monitoring is used for the acute setting in the hospital. Such monitoring is capable of detecting all rhythm disturbances over a period of time. Admitting a patient with symptoms suggestive of bradycardia and then placing the patient on a monitor are usually unproductive steps unless the patient is having frequent and severe episodes. Thus, the first-line approach is long-term monitoring, as long as this approach is considered safe. External event recorders can document episodes of symptomatic SB, but their yield will depend on the frequency of the episodes. In some instances, these events can be difficult to capture because of their episodic nature; in these cases, an implantable loop recorder that continuously records and erases the cardiac rhythm (but has memory) may be optimal. This leadless implant can record and save episodes automatically or can be triggered manually.

The Holter monitor, a continuous 24-hour ambulatory monitor, has the advantage of determining all heart rhythms, symptomatic or asymptomatic, during the recording period and therefore helps determine the presence or absence of SND; however, correlative information relating rhythm and symptoms is often lacking.

Electrophysiology testing can be used to determine SND. The test includes a measurement for SA conduction time and sinus node recovery time. Both of these measurements have a low degree of sensitivity, and the specificity is essentially unknown. Thus, the utility of the electrophysiology test is relatively uncertain, and it is not routinely used to diagnose or exclude the arrhythmia.

Autonomic testing is generally not performed to determine the effect of parasympathetic and sympathetic activation as a cause for changes in heart rate. In patients with syncope in whom a neurocardiogenic reflex is suspected but not diagnosed with certainty, the tilt table test may be helpful in determining its presence. The tilt table test has an unclear specificity and sensitivity, and there is no gold standard to determine the presence or absence of the neurocardiogenic reflex and the relationship of this reflex to SB or asystole. The accuracy with which this test predicts the cause of syncope is dependent on both the protocol and the patient. In a patient with apparent asystolic episodes caused by suspected SND, the tilt table test may be helpful in distinguishing an autonomic reflex from SND.

For the patient with recent syncope or severe symptoms thought to be due to SND, hospital admission is required, especially for those with multiple medical problems, those who have been injured, and those who are older. Acute treatment is needed if there are severe symptoms or serious sequelae of bradycardia ( Tables 1.1 and 1.2 ).

Table 1.1

Sinus Node Dysfunction and Sinus Bradycardia Management

Setting Therapy

  • No therapy required. There is some relationship between the presence of sleep apnea and sinus node dysfunction; some reports have suggested that permanent pacing, even in asymptomatic patients, may benefit sleep apnea.

  • Identify and treat associated medical conditions such as hypothyroidism.

  • Avoid rate-slowing drug if feasible.


  • Treat reversible causes. Consider drugs as the cause (β-adrenergic blockers, calcium channel blockers, and digoxin, antiarrhythmic drugs [sotalol, amiodarone, flecainide, and propafenone]). A drug may be a contributor, but until the problem resolves, treatment will be required.

  • Atropine 0.6-2 mg intravenous every 5 min, up to a total of 2 mg. Low doses and slow infusion may cause paradoxical bradycardia due to increase in sinus rate and degree of AV block. Atropine will not work for heart transplant patients. This is only a short-term solution.

  • Isoproterenol 1-5 mcg/min is effective but can exacerbate myocardial ischemia. Do not give to patients with unstable coronary artery disease. Isoproterenol is rarely indicated and should only be considered in extreme conditions when a temporary pacemaker is not available.

  • Temporary pacemaker (preferably atrial, if AV conduction is intact and the bradycardia is not due to high vagal tone) when unstable and episodes are prolonged, persistent, highly symptomatic, recurrent, or unresponsive to acute medical therapy, such as atropine or isoproterenol, or with bradycardia-associated ventricular arrhythmias (e.g., torsades de pointes). Temporary pacing may be used if permanent pacing is not possible, not indicated, or dangerous (such as the presence of an ongoing infection). Temporary pacing can be accomplished by epicardial wires (after cardiovascular surgery) or by temporary balloon-tipped catheters placed percutaneously with or without fluoroscopy (unreliable) or a temporary bipolar lead (screw in or not) that is more reliable. Placement of a temporary pacemaker can be associated with adverse events. It should be undertaken only if there is a long-term need to pace but there is no immediate permanent pacemaker placement availability (e.g., patients with recurrent syncope who on monitoring have pauses of 5 s or more, symptomatic or not). Temporary pacing is not indicated if there are prolonged pauses caused by neurocardiogenic reasons (e.g., vasovagal syncope, suctioning, endoscopy, vomiting, and cough).

  • Transcutaneous pacing may be used emergently prior to placement of a temporary pacing lead. It is highly unreliable and painful. It is not very effective over time and is hardly ever indicated. It could be used for a patient who has precipitous hemodynamic collapse due to persistent or recurrent asystole. It has not been shown to reduce the risk of death but occasionally can be used until an adequate temporary pacemaker is placed. Most patients with episodic asystole do not fit into the category of having a life-threatening arrhythmia, but patients with prolonged and recurrent asystole might fit into this category, especially if the patient is older and has underlying heart disease. Transcutaneous pacing is not stable over time because of impedance changes between the large electrodes and myocardium; moreover, adequate sedation is usually necessary to prevent pain.


  • Permanent pacemaker:

    • Class I (ACC/AHA recommended) indications: Documented symptomatic SB, including frequent pauses that cause symptoms; symptomatic bradycardia occurring as a consequence of essential long-term drug therapy at a dose and type for which there are no acceptable alternatives; symptomatic chronotropic incompetence.

    • Class IIa (ACC/AHA accepted, not mandatory, well substantiated) indications: Sinus node dysfunction from necessary drug therapy with HR < 40 bpm when a clear association between presence of bradycardia and significant symptoms has not been documented; syncope of undetermined origin with major abnormalities in sinus node dysfunction found at electrophysiology (EP) study.

    • Class IIb (ACC/AHA accepted, not mandatory, less well substantiated): Minimally symptomatic patients with chronic awake HR < 40 bpm.

  • Temporary transvenous pacemaker, if severe symptoms associated with HR < 30 bpm, unresponsive to acute medical therapy (e.g., atropine, isoproterenol) or bradycardia-associated ventricular arrhythmias (e.g., torsades de pointes). Temporary pacing is rarely indicated for chronic symptomatic problems unless there are frequent recurrences of symptomatic pauses or bradycardia.

Only gold members can continue reading. Log In or Register to continue

Jan 30, 2019 | Posted by in CARDIOLOGY | Comments Off on Sinus Node: Normal and Abnormal Rhythms

Full access? Get Clinical Tree

Get Clinical Tree app for offline access